Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Baricitinib works better than methotrexate for severe alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Significant hair regrowth doesn't always mean complete hair recovery in alopecia areata.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

The compound improves hair conditioning in shampoos.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

21-hydroxylase deficiency causes hormone imbalances leading to various symptoms, and diagnosis involves clinical and genetic tests.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.